The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Per the FDA, the recalled Cal Yee’s (or Cal Yee Farm branded) products were packaged in clear plastic zippered pouches in ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...